Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical Trial
JAMA Netw Open 2023 May 25;6(5)e2314428, JS Berger, MD Neal, LZ Kornblith, MN Gong, HR Reynolds, M Cushman, AD Althouse, PR Lawler, BJ McVerry, KS Kim, L Baumann Kreuziger, SD Solomon, MN Kosiborod, SM Berry, GV Bochicchio, M Contoli, ME Farkouh, JD Froess, S Gandotra, Y Greenstein, EM Hade, N Hanna, K Hudock, RC Hyzy, F Ibáñez Estéllez, N Iovine, AK Khanna, P Khatri, BA Kirwan, ME Kutcher, E Leifer, G Lim, RD Lopes, JL Lopez-Sendon, JF Luther, L Nigro Maia, JG Quigley, L Wahid, JG Wilson, R Zarychanski, A Kindzelski, MW Geraci, JS HochmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.